APA (7th ed.) Citation

Ng, C. M., Tang, F., Seeholzer, S. H., Zou, Y., & De León, D. D. (2018). Population pharmacokinetics of exendin‐(9‐39) and clinical dose selection in patients with congenital hyperinsulinism. British journal of clinical pharmacology, 84(3), 520-532. https://doi.org/10.1111/bcp.13463

Chicago Style (17th ed.) Citation

Ng, Chee M., Fei Tang, Steven H. Seeholzer, Yixuan Zou, and Diva D. De León. "Population Pharmacokinetics of Exendin‐(9‐39) and Clinical Dose Selection in Patients with Congenital Hyperinsulinism." British Journal of Clinical Pharmacology 84, no. 3 (2018): 520-532. https://doi.org/10.1111/bcp.13463.

MLA (9th ed.) Citation

Ng, Chee M., et al. "Population Pharmacokinetics of Exendin‐(9‐39) and Clinical Dose Selection in Patients with Congenital Hyperinsulinism." British Journal of Clinical Pharmacology, vol. 84, no. 3, 2018, pp. 520-532, https://doi.org/10.1111/bcp.13463.